Drug intelligence / Profile preview

polyglucosamine l112

Development stage
Unknown
Lead developer
Certmedica
Modality
Small Molecules, Microbiome Therapeutics, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

Polyglucosamine L112 is an indigestible dietary fiber derived from the chitin shells of crustaceans. It acts as a lipid adsorbent in the gastrointestinal tract by binding to dietary fats and cholesterol through ionic and lipophilic interactions. This physical binding forms a gel structure that reduces the absorption of fats and cholesterol in the small intestine. The primary indications are for weight reduction, weight management, and lowering LDL cholesterol levels in adults with a body mass index (BMI) of 25 or higher. Polyglucosamine L112 is used as part of a reduced-calorie diet to support treatment of overweight and obesity. Its mechanism is purely physical—no pharmacological or metabolic action occurs—and it has been shown in clinical studies to result in significant weight loss compared to placebo when combined with caloric restriction[1][2][4][6].

Brand names
formoline L112formoline L112 EXTRASterolsan
Other names
polyglucosamine l112chitosan derivative L112

Beyond the preview

Go deeper on polyglucosamine l112.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyglucosamine l112.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call